Insuman Comb 30

Insulin Human, the active ingredient in Insuman Comb 30, is an insulin presented as a premixed insulin injection for subcutaneous use. It treats type 1 and type 2 diabetes mellitus in adults and children as appropriate.

GNH USA supplies Insuman Comb 30 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insuman Comb 30 is a premixed insulin that provides basal and prandial coverage for diabetes management.

- Type 1 diabetes mellitus: supplies combined rapid‑acting and intermediate‑acting insulin to control fasting and post‑prandial glucose. - Type 2 diabetes mellitus: adds insulin therapy when oral agents no longer achieve target glycaemia. - Diabetes mellitus (general): offers a convenient fixed‑ratio insulin formulation for patients requiring both basal and mealtime insulin.

Common Side Effects: - Hypoglycaemia: low blood glucose episodes, especially if meals are missed or activity is increased. - Injection site reactions: redness, swelling or itching at the injection site. - Weight gain: increased adipose tissue due to enhanced glucose utilization. - Lipodystrophy: localized fat accumulation or loss with repeated injections. - Edema: mild peripheral swelling, often transient. - Nausea: occasional gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe hypoglycaemia: can lead to loss of consciousness or seizures. - Allergic reactions: including urticaria, angioedema or anaphylaxis. - Insulin‑induced edema leading to heart failure exacerbation. - Hypokalemia: low potassium levels in rare cases.

Before using Insuman Comb 30, consider the following precautions: - Blood glucose monitoring: adjust dose based on regular self‑monitoring. - Illness or stress: may require temporary dose increase. - Renal or hepatic impairment: use with caution and monitor closely. - Hypoglycaemia unawareness: patients should be educated on recognizing symptoms. - Pregnancy and breastfeeding: discuss risks and benefits with a healthcare professional. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Comb 30 may interact with several drug classes.

Major Interactions (Avoid): - Sulfonylureas or meglitinides: combined use can cause severe hypoglycaemia. - Beta‑blockers: may mask hypoglycaemia symptoms, requiring closer monitoring.

Moderate Interactions (Monitor Closely): - Corticosteroids: can raise blood glucose, possibly necessitating dose adjustment. - Thiazide diuretics: may increase insulin resistance and glucose levels. - Oral contraceptives: hormonal changes can affect insulin requirements.